beta 2-glycoprotein I, lipopolysaccharide and endothelial TLR4: Three players in the two hit theory for anti-phospholipid-mediated thrombosis

摘要

The thrombogenic effect of p2-glycoprotein I ((32GPI)-dependent anti-phospholipid antibodies (aPL) in animal models was found to be LPS dependent. Since (32GPI behaves as LPS scavenger, LPS/P2GPI complex was suggested to account for in vitro cell activation through LPS/TLR4 involvement being LPS the actual bridge ligand between (32GPI and TLR4 at least in monocytes/macrophages. However, no definite information is available on the interaction among p2GPI, LPS and endothelial TLR4 in spite of the main role of endothelial cells (EC) in clotting. To analyse at the endothelial level the need of LPS, we investigated the in vitro interaction of P2GPI with endothelial TLR4 and we assessed the role of LPS in such an interaction.To do this, we evaluated the direct binding and internalization of P2GPI by confocal microscopy in living TLR4-MD2 transfected CHO cells (CHO/TLR4-MD2) and P2GPI binding to CHO/TLR4-MD2 cells and human umbilical cord vein EC (HUVEC) by flow cytometry and cell-ELISA using anti-P2GPI monoclonal antibodies in the absence or presence of various concentrations of exogenous LPS. To further investigate the role of TLR4, we performed anti-p2GPI antibody binding and adhesion molecule up-regulation in TLR4-silenced HUVEC.Confocal microscopy studies show that B2GPI does interact with TLR4 at the cell membrane and is internalized in cytoplasmic granules in CHO/TLR4-MD2 cells. P2GP1 binding to CHO/TLR4-MD2 cells and HUVEC is also confirmed by flow cytometry and cell-ELISA, respectively. The interaction between P2GPI and TLR4 is confirmed by the reduction of anti-P2GPI antibody binding and by the up-regulation of E-selectin or ICAM-1 by TLR4 silencing in HUVEC. P2GPI binding is not affected by LPS at concentrations comparable to those found in both P2GPI and antibody preparations. Only higher amount of LPS that can activate EC and up-regulate TLR4 expression are found to increase the binding.Our findings demonstrate that P2GPI interacts directly with TLR4 expressed on EC, and that such interaction may contribute to P2GPI-dependent aPL-mediated EC activation. At variance of monocytic cells, we also showed a threshold effect for the action of LPS, that is able to enhance anti-P2GPI antibody EC binding only at cell activating concentrations, shown to increase TLR4 expression. This in vitro model may explain why LPS behaves as a second hit increasing the expression of P2GPI in vascular tissues and triggering aPL-mediated thrombosis in experimental animals.